As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
Survival Rates Following Cord Blood Transplant Equal Among Races
October 15, 2024
October Issue of AABB News Focuses on the Evolution of Biotherapies
October 15, 2024
AABB Releases CABP Exam Prep Bootcamps
October 14, 2024